Abstract
The Aurora family of serine/threonine kinases are mitotic regulators involved in centrosome duplication, formation of the bipolar mitotic spindle and the alignment of the chromosomes along the spindle. These proteins are frequently overexpressed in tumor cells as compared to normal cells and are therefore potential therapeutic oncology targets. An Aurora A high throughput screen revealed a promising sub-micromolar indazole-benzimidazole lead. Modification of the benzimidazole portion of the lead to a C2 linker with a phenyl ring was proposed to achieve novelty. Docking revealed that a conjugated linker was optimal and the resulting compounds were equipotent with the lead. Further structure-guided optimization of substituents on the 5 & 6 position of the indazole led to single digit nanomolar potency. The homology between the Aurora A & Aurora B kinase domains is 71% but their binding sites only differ at residues 212 & 217 (Aurora A numbering). However interactions with only the latter residue may be used for obtaining selectivity. An analysis of published Aurora A and Aurora B X-ray structures reveals subtle differences in the shape of the binding sites. This was exploited by introduction of appropriately sized substituents in the 4 & 6 position of the indazole leading to Aurora B selective inhibitors. Finally we calculate the conformational energy penalty of the putative bioactive conformation of our inhibitors and show that this property correlates well with the Aurora A binding affinity.







Similar content being viewed by others
References
Andrews PD, Knatko E, Moore WJ, Swedlow JR (2003) Curr Opin Cell Biol 15:672
Bischoff JR, Plowman GD (1999) Trends Cell Biol 9:454
Katayama H, Brinkley WR, Sen S (2003) Cancer Metastasis Rev 22:451
Fu J, Bian M, Jiang Q, Zhang C (2007) Mol Cancer Res 5:1
Nigg EA (2001) Nat Rev Mol Cell Biol 2:21
Goto H, Yasui Y, Nigg EA, Inagaki M (2002) Genes Cells 7:11
Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL, Peters JM (2003) J Cell Biol 161:281
Li X, Sakashita G, Matsuzaki H, Sugimoto K, Kimura K, Hanaoka F, Taniguchi H, Furukawa K, Urano T (2004) J Biol Chem 279:47201
Yan X, Cao L, Li Q, Wu Y, Zhang H, Saiyin H, Liu X, Zhang X, Shi Q, Yu L (2005) Genes Cells 10:617
Giet R, Prigent C (1999) J Cell Sci 112(Pt 21):3591
Cheetham GM, Knegtel RM, Coll JT, Renwick SB, Swenson L, Weber P, Lippke JA, Austen DA (2002) J Biol Chem 277:42419
Nowakowski J, Cronin CN, McRee DE, Knuth MW, Nelson CG, Pavletich NP, Rogers J, Sang BC, Scheibe DN, Swanson RV, Thompson DA (2002) Structure 10:1659
Sen S, Zhou H, White RA (1997) Oncogene 14:2195
Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A (2003) Nat Genet 34:403
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Nat Genet 20:189
Blanchard S, Deng W, Lee A, Poulsen A, Teo EL, Tu NP, William AD (2007) WO 2007/058626. S*BIO Pte Ltd., Singapore
Schrödinger (2007) Maestro, LigPrep, MarcoModel, Glide, QikProp and Jaguar are products of Schrödinger LLC, www.schrodinger.com
Chang G, Guida WC, Still WC (1989) J Am Chem Soc 111:4379
Halgren TA (1999) J Comput Chem 20:720
Hasel WH, Hendrickson TF, Still WC (1988) Tetrahedron Comput Method 1:103
Still WC, Tempczyk A, Hawley RC, Hendrickson T (1990) J Am Chem Soc 112:6127
Sessa F, Mapelli M, Ciferri C, Tarricone C, Areces LB, Schneider TR, Stukenberg PT, Musacchio A (2005) Mol Cell 18:379
Bostrom J, Norrby PO, Liljefors T (1998) J Comput Aided Mol Des 12:383
Tannor DJ, Marten B, Murphy R, Friesner RA, Sitkoff D, Nicholls A, Honig B, Ringnalda M, Goddard WA (1994) J Am Chem Soc 116:11875
Renhowe PA, Shafer CM, McBride C, Silver J, Pecchi S, Machajewski T, McCrea B, Poon D, Thomas T (2003) WO2003/004488. Chiron Corporation, USA
Blanchard S, Ethirajulu K, Lee CHA, Nagaraj HKM, Poulsen A, Sun ET, Tan YLE, Teo EL, William AD (2006) WO2007/058628. S*BIO PTE LTD, Singapore
Blanchard S, Lee CHA, Nagaraj HKM, Poulsen A, Sun ET, Tan YLE, William AD (2006) WO2007/058627. S*BIO PTE LTD, Singapore
Bissantz C, Folkers G, Rognan D (2000) J Med Chem 43:4759
Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Nat Rev Drug Discov 3:935
Tame JR (2005) J Comput Aided Mol Des 19:445
Wang R, Lu Y, Wang S (2003) J Med Chem 46:2287
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) J Med Chem 47:1739
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) J Med Chem 49:6177
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) J Med Chem 47:1750
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poulsen, A., William, A., Lee, A. et al. Structure-based design of Aurora A & B inhibitors. J Comput Aided Mol Des 22, 897–906 (2008). https://doi.org/10.1007/s10822-008-9224-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-008-9224-5